Viewing Study NCT00383994

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2025-12-26 @ 12:23 AM
Study NCT ID: NCT00383994
Status: COMPLETED
Last Update Posted: 2019-07-31
First Post: 2006-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Leukemia View
None Transplantation, Stem Cell View
None Lymphoid Malignancies View
None Disorder Related to Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Lymphocytic Leukemia View
None CLL View
None Non-Hodgkin's Lymphoma View
None B-Cell Lymphoma View
None Lymphoma View
None granulocyte-macrophage colony-stimulating factor View
None Leukemia View
None NK Cells View
None Rituximab View
None GM-CSF View
None Non-myeloablative Allogeneic Stem Cell Transplantation View
None Stem Cell Transplant View